Daiwa Securities Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,032
Closed -$105K 1371
2023
Q3
$105K Buy
6,032
+828
+16% +$17.3K ﹤0.01% 1012
2023
Q2
$108K Buy
5,204
+537
+12% +$11.7K ﹤0.01% 992
2023
Q1
$110K Buy
4,667
+501
+12% +$13.5K ﹤0.01% 981
2022
Q4
$116K Buy
4,166
+501
+14% +$12.8K ﹤0.01% 979
2022
Q3
$86K Buy
3,665
+394
+12% +$11.9K ﹤0.01% 1016
2022
Q2
$110K Buy
3,271
+451
+16% +$15.8K ﹤0.01% 1015
2022
Q1
$99K Buy
2,820
+255
+10% +$8.72K ﹤0.01% 1042
2021
Q4
$78K Buy
2,565
+42
+2% +$1.37K ﹤0.01% 1050
2021
Q3
$83K Buy
2,523
+256
+11% +$8.19K ﹤0.01% 1006
2021
Q2
$69K Buy
+2,267
New +$74.6K ﹤0.01% 971

Other funds holding OGN

Daiwa Securities Group's OGN Position: Q4 2023 in Review

Daiwa Securities Group sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 6,032 shares — an estimated $105K sold.

Daiwa Securities Group first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $116K in Q4 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Daiwa Securities Group reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 6,032 Organon & Co shares in Q4 2023, an estimated $105K.
  • Daiwa Securities Group first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Daiwa Securities Group's Organon & Co position peaked at $116K in Q4 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.